Discontinuation report ACT LOSARTAN

Last updated on 2018-10-22 History
Report ID 65315
Drug Identification Number 02354837
Brand name ACT LOSARTAN
Common or Proper name LOSARTAN
Company Name ACTAVIS PHARMA COMPANY
Market Status CANCELLED POST MARKET
Active Ingredient(s) LOSARTAN POTASSIUM
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-07-31
Remaining supply date 2018-08-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned. TEVA available
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-10-22 French Compare
v2 2018-10-22 English Compare
v1 2018-10-22 English Compare